Optimizing Glaucoma Management: Clinical and Cost Concerns for Managed Care

An Independently Offered CPE-Accredited Satellite Symposium

Live Symposium

Optimizing Glaucoma Management: Clinical and Costs Concerns for Managed Care

Thursday, April 8
San Diego Marriott Hotel and Marina
Marina Ballroom D
Located in the South Tower, Level 3
Registration/Dinner—7:00 pm to 7:30 pm
Interactive Symposium—7:30 pm to 9:30 pm

Sponsored by North American Center for Continuing Medical Education, LLC

Presenters/Q&A Cohosts

Robert D. Fechtner, MD
Professor of Ophthalmology
Director, Glaucoma Division
Institute of Ophthalmology and Visual Science
New Jersey Medical School, UMDNJ
Newark, New Jersey

Clark Springs, MD
Assistant Professor
Director, Cornea and Refractive Surgery
Glick Eye Institute
Indiana University School of Medicine
Indianapolis, Indiana

Moderator/Q&A Cohost

Randall Seifert, PharmD
Professor, Department of Pharmacy Practice and Pharmaceutical Sciences
Senior Associate Dean
University of Minnesota
College of Pharmacy
Minneapolis, Minnesota

Learning Objectives

Upon completing this activity, participants should be able to:

Chart the total clinical and economic burden of glaucoma and disease sequelae
Describe the importance of early diagnosis and impact of early treatment on long-term glaucoma outcomes
Interpret and apply emerging data on the safety and efficacy of available glaucoma medications
Promote evidence-based glaucoma management practices among in-plan ophthalmologists to improve outcomes

Target Audience

This activity is designed for managed markets pharmacists.

Activity Overview

Participants will obtain an activity booklet, including lecture slides and evaluation completion instructions, onsite before the symposium. Participants will be asked to complete the symposium evaluation online following the conclusion of the symposium.

The online evaluation will be available following the symposium, and will remain active for 2 weeks following the live event. Participants will be required to register for an account (existing users can sign into an existing account) with naccme.com. The evaluation must be completed in order to immediately print documentation of credit.

To be eligible for credit for this activity, completed evaluations must be submitted online by April 22, 2010.

There is no fee associated with this activity.

This educational activity is a knowledge-based activity.

For questions regarding this educational activity, please contact Angela Scarnici at 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape, or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

CPE Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 2 contact hours (0.2 CEUs) of continuing pharmacy education (UAN 276-000-10-013-L01-P).

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact John Savage, Director, Medical Education, NACCME, in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535, or by e-mail at jsavage@naccme.com. The Director of Medical Education will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Vice President, Medical Education, NACCME, may be made for a second level of review.

Independent Clinical Reviewer: Simon K. Law, MD, PharmD, Associate Professor of Ophthalmology, Jules Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, California

Planning Committee

The planning committee comprises Robert D. Fechtner, MD, Simon K. Law, MD, PharmD, Randall Seifert, PharmD, Clark Springs, MD; Kristin Dickie, Mary Johnson, Mike Kearney, Randy Robbin, John Savage, and Jessica Steuerman, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Fechtner: Grant/research support—Allergan, Inc; Consultant—Alcon Laboratories, Inc, Allergan, Inc
Dr. Law: Grant/research support—Allergan, Inc; Promotional speakers bureau—Allergan, Inc
Dr. Springs: Grant/research support—Alcon Laboratories, Inc, Inspire; Consultant—Alcon Laboratories, Inc, Allergan, Inc, Ista Pharmaceuticals, Inc, Santen Pharmaceutical; Scientific advisor—Alcon Laboratories, Inc, Ista Pharmaceuticals; Promotional speakers bureau—Alcon Laboratories, Inc, Allergan, Inc, Inspire
Dr. Seifert: Consultant—Alcon Laboratories, Inc; Employee/officer/board member—Seifert and Associates, SPC Therapeutics

Ms. Dickie, Ms. Johnson, Mr. Kearney, Mr. Robbin, Mr. Savage, and Ms. Steuerman have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed that no off-label/unapproved use(s) of drugs and/or devices will be discussed.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2010 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by an educational grant from Alcon Laboratories, Inc.

Representatives of the granting organization may not register on behalf of participants.

Click Here to Register